NCT06488456Completed
Psychometric Properties of the Therapy-Related Symptom Checklist-Children
Psychometric Properties of the Turkish Version of Therapy-Related Symptom Checklist for Children Scale
Source: ClinicalTrials.gov · Last updated 28 Feb 2025
Brief summary (registry, in English)
Diagnosis and treatment of childhood cancers is an exhausting process that affects both children and their caring parents physically and mentally. While the survival rate in childhood cancers was 28% in the 1960s, this rate has increased up to 80% with the developments in treatment methods. Although the main methods used in cancer treatment today are surgical treatment, radiotherapy, and immunotherapy, the main component of cancer treatment is chemotherapy. Improvements in chemotherapy protocols have increased survival; however, the use of high-dose chemotherapy may increase the frequency and severity of symptoms that may be seen in children. Therefore, diagnosis and management of treatment-related symptoms in the pediatric population receiving chemotherapy treatment as soon as possible is of vital importance as it will significantly affect the quality of life of children. In this context, this study aimed to add to the national literature by conducting a Turkish validity and reliability study of a checklist suitable for the use of health professionals in clinics for monitoring the side effects of chemotherapy. In the study, validity and reliability tests will be performed for intercultural scale adaptation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 300 (actual)
- First submitted
- 28 Jun 2024
- Start date
- 1 Apr 2022
- Primary completion date
- 1 Dec 2024
- Lead sponsor
- Ege University
- NCT number
- NCT06488456
What you commit to
- Study type: Observational
- Participants enrolled: 300
- From 1 Apr 2022 to the primary completion date, 1 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- The patient has never received chemotherapy
Other illness
- The patient is being treated for a disease other than leukemia
Age
- The patient is younger than 2 years of age
Other
- The subject/caregiver parent does not speak Turkish
Who the study is looking for
- The patient is between 2-18 years of age
- The patient has received chemotherapy treatment at least twice,
- The patient/caregiver parent speaks Turkish and is open to communication
- Volunteering to participate in the study.
Age in the registry: 2 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ege University Coordinator of this site? Confirm its status | Izmir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.